The goal of this assessment will be to focus on the role of PTNS in the treatment of overactive bladder.

The Overactive Bladder Innovative Therapy Trial (ORBIT ... participants were allowed to select the frequency of PTNS treatment that best controlled their symptoms. These treatments were all ...

An overactive bladder may be temporary or become a chronic condition. How long the symptoms last may depend on factors like the underlying cause and treatment adherence. Some conditions may cause ...

When this happens, symptoms associated with overactive bladder are reduced ... This can include: Many factors may influence which medication is best for bladder control, including other health ...

Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J. Urol. 23 , 263–270 (2005). Article CAS PubMed Google Scholar ...

In women, causes of overactive bladder are varied, but the common consequence, beyond the physical manifestations, are frustration and embarrassment. While medications designed to relax the bladder ...

(HealthDay News) — Gemtesa (vibegron) has been approved by the US Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy ... who are receiving ...

Drugs to treat overactive bladder don't work very well, according to a recent CR Best Buy Drugs analysis ... relief of their symptoms while taking a medication, especially for longer periods ...